BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 19459317)

  • 21. [Study on antihyperlipidemia effects of Chinese medicine].
    Wang J; Zhang JS
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1005-8. PubMed ID: 17672328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge discovery in traditional Chinese medicine: state of the art and perspectives.
    Feng Y; Wu Z; Zhou X; Zhou Z; Fan W
    Artif Intell Med; 2006 Nov; 38(3):219-36. PubMed ID: 16930966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Probing into objectivity of adverse drug reaction of traditional Chinese medicine].
    Sun YQ; Ma YG; Xing XY; Xiao XH
    Zhongguo Zhong Yao Za Zhi; 2006 Aug; 31(16):1381-3. PubMed ID: 17061563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of Chinese herbs and its compound prescription guided by traditional Chinese medical theory].
    Wang J; Jing L
    Zhongguo Zhong Yao Za Zhi; 2003 Sep; 28(9):795-8. PubMed ID: 15015366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current situation of toxicity classification of Chinese materia medica and its research thoughts].
    Sun W; Hou X; Wang B; Zhu Y; Zhang S; Chang H; Sun J
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2199-201. PubMed ID: 23189717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Discussion on role of enterprises in re-evaluation of traditional Chinese medicine injection].
    Li X; Song L; Liu Y; Bo Y
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1326-8. PubMed ID: 19673401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent highlights of metabolomics for traditional Chinese medicine.
    Zhang A; Sun H; Wang X
    Pharmazie; 2012 Aug; 67(8):667-75. PubMed ID: 22957430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advance of research on toxic attenuation by compatibility of traditional Chinese medicine prescriptions].
    Guo H; Li W; Wang X; Fan G
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):120-3. PubMed ID: 22741475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabonomics and the modernization of traditional Chinese medicine].
    Liang YZ; Yu Y; Yi ZB; Yi LZ; Wang P; Wang YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):823-6. PubMed ID: 18595266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research on compatibility chemistry of acid-alkaline pair medicines in formulas of traditional Chinese medicine].
    Pei M; Duan X; Pei X; Xuan C; Wang X; Zhao L; Zhang S; Liu B; Wang S
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1989-93. PubMed ID: 19894549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Systems biology and traditional Chinese medicine (TCM) modernizatin].
    Zhang JY; Wang QG; Wang Z
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(22):1725-7, 1766. PubMed ID: 16468364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Traditional toxicity documentation of Chinese Materia Medica--an overview.
    Leung AY
    Toxicol Pathol; 2006; 34(4):319-26. PubMed ID: 16787890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicities by herbal medicines with emphasis to traditional Chinese medicine.
    Efferth T; Kaina B
    Curr Drug Metab; 2011 Dec; 12(10):989-96. PubMed ID: 21892916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development.
    Wu KM; Farrelly JG; Upton R; Chen J
    Phytomedicine; 2007 Apr; 14(4):273-9. PubMed ID: 16863692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Illumination of pharmacoeconomics on Chinese herbal medicine inject].
    Zhang F; Zhou CF
    Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(5):453-6. PubMed ID: 17511156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Herbal CONSORT statement and standardization of reporting traditional Chinese drug trials].
    Fei YT; Liu JP
    Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):89-94. PubMed ID: 18338628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging issues in traditional Chinese medicine.
    Siow YL; Gong Y; Au-Yeung KK; Woo CW; Choy PC; O K
    Can J Physiol Pharmacol; 2005 Apr; 83(4):321-34. PubMed ID: 15877107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recognition on toxicity of traditional Chinese drugs].
    Yu CQ; Shi JR
    Zhong Xi Yi Jie He Xue Bao; 2003 Nov; 1(4):252-4. PubMed ID: 15339522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.